HCGB FROM CERVICAL CANCER: PEPTIDE HETEROGENITY
HCGB FROM CERVICAL CANCER: PEPTIDE HETEROGENITY
批准号:
3166109
负责人:
ROLAND A PATTILLO
金额:
$11.64万
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-05-01 至 1987-12-31
中文摘要
Dot和CaSki人癌细胞异位分泌hCG-β
包含两个组分,异位hCG-β-I和异位hCG-β-II。
异位hCG-β-II缺乏C端肽(CTP),基于缺乏
被CTP抗体识别,缺乏易感性
嗜热溶血素(通常切割CTP),以及缺乏结合
花生凝集素(AH)的去分析衍生物(专用于
CTP上O-连接低聚糖的Gal-GalNAc)。免疫反应阳性
18例中有13例的血清或尿液中检测到类似人绒毛膜促性腺激素的物质
宫颈癌患者。大型滚筒瓶的使用条件
对CaSki宫颈癌细胞的培养进行了优化。一种方法,用于
异位hCG-β-I和hCG-β-II的分离已经得到验证,
涉及差示亲和层析:(1)\抗hCG-α
琼脂糖基;(2)反[CTP导向]hCG-β-琼脂糖基;
(3)反义[核心导向]hCG-β琼脂糖凝胶。异位hCG-β-II被洗脱
从第三阶段开始,用4M盐酸胍,pH为3,脱盐。这个
纯化的异位hCG-β-II未能与标准hCG-α结合
在标准hCG-β和标准hCG-α结合的条件下。
获得的证据表明,食物中含有额外的碳水化合物
异位hCG-β。含免疫活性物质的DOT和CaSki培养液
明显比标准hCG-β更大的类似hCG-β的成分
(取自妊娠尿hCG),经凝胶过滤和钠盐过滤证实
十二烷基硫酸酯凝胶电泳法(后者在孵育后
含有放射性氨基酸的CaSki细胞)。(C)
英文摘要
Ectopic hCG-beta secreted by DoT and CaSki human carcinoma cell lines
contains two components, ectopic hCG-beta-I and ectopic hCG-beta-II.
Ectopic hCG-beta-II lacks the C-terminal peptide (CTP), based on lack of
recognition by antibodies against CTP, lack of susceptibility to
thermolysin (which normally cleaves the CTP), and lack of binding of the
desialylated derivative to Arachis hypogaea (AH) lectin (specific for
Gal-GalNAc of the O-linked oligosaccharides on the CTP). Immunoreactive
hCG-beta-like material has been detected in the serum or urine of 13 of 18
patients with cervical carcinoma. Conditions for large-scale roller bottle
culture of CaSki cervical carcinoma cells were optimized. A method to
separate ectopic hCG-beta-I from ectopic hCG-beta-II has been validated and
involves differential affinity chromatography with: (1)\anti-hCG-alpha
Sepharose; (2)\anti-[CTP-directed]hCG-beta-Sepharose; and
(3)\anti-[core-directed]hCG-beta Sepharose. Ectopic hCG-beta-II is eluted
from the third stage with 4 M guanidine\HC1, pH 3, and desalted. The
purified ectopic hCG-beta-II failed to combine with standard hCG-alpha
under conditions where standard hCG-beta combined with standard hCG-alpha.
Evidence was obtained for the presence of additional carbohydrates on
ectopic hCG-beta. DoT and CaSki culture fluids contained immunoreactive
hCG-beta-like components of apparently larger size than standard hCG-beta
(from pregnancy urine hCG) as demonstrated by gel filtration and sodium
dodecyl sulfate-gel electrophoresis (the latter following incubation of
CaSki cells with radioactive amino acids). (C)
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The hCG assay in the treatment of trophoblastic disease.
hCG 测定在治疗滋养细胞疾病中的应用。
DOI:
--
发表时间:
1984
期刊:
The Journal of reproductive medicine
影响因子:
--
作者:
[Pattillo,RA, Hussa,RO]
通讯作者:
Hussa,RO
Production of tumor-associated antigen, TA-4, by the CaSki cervical carcinoma cell line.
CaSki 宫颈癌细胞系产生肿瘤相关抗原 TA-4。
DOI:
10.1097/00006250-198606000-00010
发表时间:
1986
期刊:
Obstetrics and gynecology
影响因子:
7.2
作者:
[Hussa,RO, Maruo,T, Strobel,JL, Pattillo,RA, Mochizuki,M]
通讯作者:
Mochizuki,M
Optimization of the production of hCG beta-like material by CaSki human cervical carcinoma cells in roller bottle culture.
CaSki 人宫颈癌细胞在滚瓶培养中优化 hCG β 样物质的生产。
DOI:
10.1159/000226105
发表时间:
1986
期刊:
Oncology
影响因子:
3.5
作者:
[Hussa,RO, Pattillo,RA, Ruckert,AC, Rinke,ML, Cortesi,JP, Fein,HG]
通讯作者:
Fein,HG
A procedure using immobilized antibody for the isolation of the beta-subunit of human chorionic gonadotropin from the culture fluid of a beta-subunit-secreting nontrophoblastic cell line.
使用固定化抗体从分泌 β 亚基的非滋养细胞系培养液中分离人绒毛膜促性腺激素 β 亚基的方法。
DOI:
10.1210/jcem-53-5-1090
发表时间:
1981
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
[Story,MT, Cole,LA, Hussa,RO]
通讯作者:
Hussa,RO
Discordant synthesis and secretion of human chorionic gonadotropin and subunits by cervical carcinoma cells.
宫颈癌细胞合成和分泌人绒毛膜促性腺激素及其亚基的不一致。
DOI:
--
发表时间:
1981
期刊:
Cancer research
影响因子:
11.2
作者:
[Cole,LA, Hussa,RO, Rao,CV]
通讯作者:
Rao,CV
共 11 条
海外基金